AURA
Aura BiosciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
AURA vs peer average
52/100
AURA vs. peer average (D vs. D)
Grade spread
A 1 · C 1 · D 3 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ACRS is the first available peer comparator.
Similar small-cap biotechnology valuation context, but not a direct ocular oncology or bel-sar comparator.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AURA
Aura Biosciences
ACRS
Aclaris Therapeutics
Grade
D
C
Momentum
49
5
Value
41
41
Sentiment
53
77
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs ACRS
AURA / ACRS
Grade Position
In line
AURA vs. peer average (D vs. D)
52/100
Momentum
49
AURAValue
41
AURASentiment
53
ACRSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AURA
ACRS is the first peer returned for this comparison set.